Pathways to breast cancer screening artificial intelligence algorithm validation

As more artificial intelligence (AI)-enhanced mammography screening tools enter the clinical market, greater focus will be placed on external validation in diverse patient populations. In this viewpoint, we outline lessons learned from prior efforts in this field, the need to validate algorithms on...

Full description

Saved in:
Bibliographic Details
Published in:Breast (Edinburgh) Vol. 52; pp. 146 - 149
Main Authors: Lee, Christoph I., Houssami, Nehmat, Elmore, Joann G., Buist, Diana S.M.
Format: Journal Article
Language:English
Published: Netherlands Elsevier Ltd 01.08.2020
Elsevier
Subjects:
ISSN:0960-9776, 1532-3080, 1532-3080
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:As more artificial intelligence (AI)-enhanced mammography screening tools enter the clinical market, greater focus will be placed on external validation in diverse patient populations. In this viewpoint, we outline lessons learned from prior efforts in this field, the need to validate algorithms on newer screening technologies and diverse patient populations, and conclude by discussing the need for a framework for continuous monitoring and recalibration of these AI tools. Sufficient validation and continuous monitoring of emerging AI tools for breast cancer screening will require greater stakeholder engagement and the creation of shared policies and guidelines.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0960-9776
1532-3080
1532-3080
DOI:10.1016/j.breast.2019.09.005